GlassScriptPhysician profile
James A Blair
NPI 1881856110
$416,665.59
in general payments reported to CMS, 2019-2025
28 companies · $119K in 2025
The $119K reported for 2025 was more than what 96% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $5,464 · 2021: $29K · 2022: $46K · 2023: $99K · 2024: $108K · 2025: $119K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $197K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $70K · Travel and Lodging: $41K · Food and Beverage: $11K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,500 · Honoraria: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $197,058.52 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $69,672.50 |
| Travel and Lodging | $41,047.56 |
| Food and Beverage | $11,323.94 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,500.00 |
| Honoraria | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $112,610.29 | 2019-2025 | Evos, Evos Mini, Trigen Intertan |
| Stryker Corporation | $106,367.73 | 2019-2025 | T2 Alpha, Pangea, Gamma |
| Globus Medical, INC. | $54,706.70 | 2023-2025 | Precice® Intramedullary Limb Lengthening System, Autobahn, Precice Intramedullary Limb Lengthening System |
| Medical Device Business Services, INC. | $38,487.19 | 2023-2025 | Na, Tomofix |
| Integra Lifesciences Corporation | $33,309.67 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Orthofix Medical, INC. | $25,046.00 | 2024-2025 | Truelok, Fitbone, Tl-Hex Truelok Hexapod System |
| Synthes Gmbh | $18,030.71 | 2020-2024 | |
| Nuvasive Specialized Orthopedics, INC. | $15,975.29 | 2019-2023 | Precice Intramedullary Limb Lengthening System |
| Nuvasive, INC. | $5,000.00 | 2019 | |
| Illuminoss Medical, INC. | $4,710.30 | 2021-2025 | Photodynamic Bone Stabilization Procedure Pack |
| Depuy Synthes Sales INC. | $644.48 | 2019-2025 | Na, Tfn-Advance |
| Bone Support INC. | $354.64 | 2020-2024 | Ceramentbone Void Filler, Cerament G |
| Paragon 28, INC. | $276.91 | 2023 | Additive Orthopedics |
| Bioventus LLC | $245.68 | 2020-2023 | Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $172.69 | 2020-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $122.88 | 2022 | |
| Vericel Corporation | $117.10 | 2021 | |
| Abbott Laboratories | $84.81 | 2023 | Aveir, Confirm Rx |
| Polarityte, INC. | $84.75 | 2020 | |
| Si-Bone, INC. | $65.15 | 2021 | |
| Kci USA, INC. | $47.56 | 2020-2021 | |
| Polynovo North America LLC | $46.33 | 2021 | |
| Baxter Healthcare | $44.89 | 2022-2024 | Floseal |
| Djo, LLC | $33.33 | 2019 | |
| Biocomposites INC | $32.27 | 2024 | |
| Hydrofera LLC | $20.65 | 2022 | |
| Acumed LLC | $16.40 | 2019 | |
| Pacira Therapeutics, INC. | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Blair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.